S-4 Filing

The deal was announced in April at a pro forma enterprise value of $426 million. If the deal is approved, OpSec Group would likely trade on the Nasdaq, where Investcorp Europe I presently lists.

Tokyo-based SBC Medical Group specializes in medical care and special treatment including cosmetic surgery, infertility, dental, and orthopedics.

A firm date for a shareholder vote was not cited in the proxy, although a vote is to be held sometime this month.

The company manages Cessna Citation aircraft with a floating fleet of over 90 jets with access to a network of personalized private aviation and on-demand flights that can service a myriad of specialized trip needs.

Dune in August lowered the consideration to be paid to Global Hydrogen from $57.5 million to $48 million.

The SPAC last month announced a merger agreement with Bolt Threads, which produces sustainable biomaterials for consumer products. The deal has a $346.1 million pro forma enterprise valuation.

Pearl Holdings in June said it signed a letter of intent with an unnamed target for a potential business combination. That gave the SPAC an automatic extension up to the current Dec. 17 deadline, although no mention is made in the proxy of the LOI or any progress on a potential business combination.  

A vote on the Starton merger was pushed back twice in October, then postponed. The shareholder meeting was to be rescheduled “as soon as practicable,” the SPAC said at the time.

Redwoods has a $94 million deal in hand with ANEW MEDICAL, an early-stage biotechnology company focused on developing disruptive new therapies to treat neurodegenerative diseases.

Terms call for the SPAC to issue $275 million in stock to the combined enterprise, plus 20 million earnout shares. There is a minimum $25 million condition to close.